Behavioral Effects of Stimulated Dopamine Release and D2-like Receptor Displacement in Parkinson’s Patients with Impulse-Control Disorder
Open Access
- 19 April 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3866
Abstract
Dysregulated dopamine (DA) release in the mesocorticolimbic circuit is noted in Parkinson’s disease (PD) patients with impulsive and compulsive behaviors (ICBs). However, the effect of acute DA release on mood, the localization of this process, and the phenotypic differences in patients with ICB remain unknown. We applied a placebo-controlled dextro-amphetamine (dAMPH) study in 20 PD patients: 10 with ICBs (PD-ICB) and 10 without (PD-C). Subjective mood experiences were measured with well-described self-reported measures including the Positive and Negative Affect Scale (PANAS), Drug Effects Questionnaire (DEQ), and Amphetamine Interview Rating Scale (AIRS). D2-like receptor availability was measured as non-displaceable binding potential (BPND) using PET imaging with the high-affinity D2/3 receptor ligand [18F]-fallypride. Among all the subjects, dAMPH increased the PANAS positive, DEQ feel, DEQ high, and AIRS total scores. Increases in the PANAS positive and AIRS total scores were greater in the PD-ICB cohort. A mixed-effects model correlated these questionnaire changes with dAMPH-induced reductions in BPND in the ventral striatum (VS), caudate, amygdala, and caudo-medial orbitofrontal cortex. The baseline caudate, VS, and amygdala BPND positively correlated with lower on-dAMPH PANAS positive scores. Elevated mood symptoms of acute dAMPH administration in PD are linked to DA release in the mesocorticolimbic regions. Distinctions in behavioral effects among PD-ICB subjects emphasize that dysregulated striatal and extra-striatal DA-ergic networks alter mood responses to stimulated DA release and may also contribute to behavioral changes resulting from DA-targeting therapies in PD.Keywords
Funding Information
- National Institute on Aging Grant (1K24AG064114, 5R01NS097783)
- National Institute of Neurological Disorders and Stroke (1K24AG064114, 5R01NS097783)
This publication has 69 references indexed in Scilit:
- Self‐reported rates of impulsivity in Parkinson’s DiseaseAnnals of Clinical and Translational Neurology, 2020
- Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's diseaseMovement Disorders, 2019
- Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating ScaleMovement Disorders, 2011
- Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [18F]fallyprideSynapse, 2010
- Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's diseaseMovement Disorders, 2009
- Dopamine transporters, D2receptors, and dopamine release in generalized social anxiety disorderDepression and Anxiety, 2009
- Functional Abnormalities Underlying Pathological Gambling in Parkinson DiseaseArchives of Neurology, 2008
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing planMovement Disorders, 2007
- Compulsive drug use linked to sensitized ventral striatal dopamine transmissionAnnals of Neurology, 2006
- Mood changes and “on‐off” phenomena in Parkinson's diseaseMovement Disorders, 1990